GSK Objects To Abbott’s Proposed Norvir Settlement

Law360, New York (August 17, 2008, 12:00 AM EDT) -- A proposed settlement between Abbott Laboratories and a class of indirect purchasers of Norvir that is contingent upon the acceptance of an interlocutory appeal has drawn opposition from GlaxoSmithKline Plc and other plaintiffs that have filed related suits alleging the drug company unfairly jacked up the price of the HIV medication.

Abbott and the indirect purchasers entered into a potential settlement in July on the condition that the U.S. District Court for the Northern District of California certifies and the Ninth Circuit accepts an appeal to...
To view the full article, register now.